| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, Obu | Director
2 companies
Teresa Marie Bitetti is President, Obu at TKPHF, with reported holdings spanning 2 companies. Teresa Marie Bitetti's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $10.8M at current prices.
Teresa Marie Bitetti's largest disclosed position is in TKPHF as President, Obu, worth about $10.6M. The TKPHF filings lean toward selling, a net 50,012 shares.
Teresa Marie Bitetti has 5 Form 4 filings on record from March 2025 to August 2026, across 2 companies: President, Obu at Takeda Pharmaceutical (TKPHF), 2026; Director at Aura Biosciences (AURA), 2025–2026.
The 7 reported transactions were 4 stock awards, 2 option or other derivative awards and 1 open-market sale.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $855K.
The only open-market sale was 50,012 shares of TKPHF at an average $17.10 on August 10, 2026, about $855K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | TKPHF Takeda Pharmaceutical Company Limited | President, Obu | Sell | 50,012 | $17.10 | $855,205.20 | -16.6% |